Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1).
about
Imaging aspects of cardiovascular disease at the cell and molecular level.Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditionsProfibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.Effects of plasminogen activator inhibitor-1-specific RNA aptamers on cell adhesion, motility, and tube formation.PAI-1 and diabetes: a journey from the bench to the bedside.Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseasesEndothelial function and germ-line ACE I/D, eNOS and PAI-1 gene profiles in patients with coronary slow flow in the Canakkale population: multiple thrombophilic gene profiles in coronary slow flow.Therapeutic potential of plasminogen activator inhibitor-1 inhibitors.Attenuation of accumulation of neointimal lipid by pioglitazone in mice genetically deficient in insulin receptor substrate-2 and apolipoprotein E.The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways
P2860
Q33338017-596D103A-6AB0-463D-9C43-2721EE93EA76Q34217461-86F40BA7-B7C4-43E0-8C58-A9775E1B48B6Q34452976-F3C8242A-BC1C-447E-AC11-9016231A9213Q35757741-5A542805-EC12-4DFE-AC38-00417A6D64F0Q36249561-5473AA5A-A956-48D5-892E-02F0F3FE9F98Q37017506-A675BA4D-5BAB-4714-8C70-E889527B40A8Q37646602-65ECA1DC-7CFE-43A5-BECA-2254B82CB4C9Q37775818-6B70BB2C-551C-421D-A831-7A9D5C4D5A28Q46472652-DD2CF166-44E7-47DA-B8F5-44E1236DE6D5Q58071384-189D4F90-BE54-4D56-A26B-45A77004421B
P2860
Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1).
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Attenuation of neointimal vasc ...... ator inhibitor type 1 (PAI-1).
@ast
Attenuation of neointimal vasc ...... ator inhibitor type 1 (PAI-1).
@en
type
label
Attenuation of neointimal vasc ...... ator inhibitor type 1 (PAI-1).
@ast
Attenuation of neointimal vasc ...... ator inhibitor type 1 (PAI-1).
@en
prefLabel
Attenuation of neointimal vasc ...... ator inhibitor type 1 (PAI-1).
@ast
Attenuation of neointimal vasc ...... ator inhibitor type 1 (PAI-1).
@en
P2093
P2860
P356
P1476
Attenuation of neointimal vasc ...... ator inhibitor type 1 (PAI-1).
@en
P2093
Burton E Sobel
David J Schneider
Douglas J Taatjes
Heidi Taatjes
Marilyn Wadsworth
Mercedes Rincón
Michael Hayes
P2860
P304
P356
10.1369/JHC.4A6260.2004
P577
2004-08-01T00:00:00Z